*Registration is Required

 

 


    

Cal Poly Pomona is proud to present the
Kellogg Distinguished Public Lecture Series
funded by the Kellogg Legacy Project Endowment.

We are please to announce our next distinguished speaker,

Professor Sir Ian Wilmut, FRS, FRSE

Professor Emeritus in the
MRC Centre for Regenerative Medicine, University of Edinburgh

Discusses
"Dolly to Stem Cell Therapy"

Thursday, February 21, 2013
Bronco Student Center - URSA Major

6pm - Reception
7pm - Lecture
8pm - Q & A Session

The entire event is open to the public, but advanced registration is required. No photography or video/audio recording.

Ian Wilmut obtained his first degree in animal science at the University of Nottingham before completing a PhD at the University of Cambridge. During a post doctoral fellowship in Cambridge he carried out the research that produced the first calves from frozen and thawed embryos.

From Cambridge he moved to the Roslin Institute near Edinburgh where he was the leader of the team that produced Dolly the sheep, the first clone from an adult animal. The group then went on to use the new methods to introduce precise genetic change into livestock so that they produced in their milk a protein that is needed to treat human disease.

He was the founding Director of the Centre for Regenerative Medicine in the University of Edinburgh. The Mission of this rapidly expanding Centre is to develop new treatments for human disease through innovative research with stem cells. Purpose designed facilities have been built alongside the new Royal Infirmary of Edinburgh. The Centre will act as a focus within the Europe not only for the research with stem cells, but also the clinical and commercial opportunities that arise from the research. The new Centre covers the full spectrum of research - from basic mechanisms of stem cell regulation, via rigorous translational studies to provide the basis for new therapies and clinical trials with stem cells and their derivatives. The aim of his research is to be able to produce human cells for use in treatment of disease.